Form D — Indaptus Therapeutics, Inc.
0001493152-25-003248 · filed 2025-01-22
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $2,246,500
- Total sold
- $2,246,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Indaptus Therapeutics, Inc.
- CIK
- 1857044
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 3 COLUMBUS CIRCLE
NEW YORK, NY 10019 - Phone
- (646) 427-2727
Related persons
-
JEFFREY A. MECKLER · Executive OfficerNEW YORK, NY
-
WALT A LINSCOTT · Executive OfficerNEW YORK, NY
-
NIR SASSI · Executive OfficerNEW YORK, NY
-
MICHAEL J. NEWMAN · Executive OfficerNEW YORK, NY
-
ROGER WALTZMAN · Executive OfficerNEW YORK, NY
-
HILA KARAH · DirectorNEW YORK, NY
-
ANTHONY J. MADDALUNA · DirectorNEW YORK, NY
-
WILLIAM B. HAYES · DirectorNEW YORK, NY
-
ROGER J. POMERANTZ · DirectorNEW YORK, NY
-
MARK J GILBERT · DirectorNEW YORK, NY
-
ROBERT E. MARTELL · DirectorNEW YORK, NY
View original on SEC EDGAR.